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ABSTRACT 
Fahr’s syndrome is an entity where there is symmetrical bilateral calcification of basal ganglia with 
parkinsonian and psychiatric symptoms. However, due to its rarity, clinicians tend not to include 
Fahr’s syndrome in their differential diagnosis. This article aims to raise awareness about the 
diagnosis of Fahr’s Syndrome through its unique presentation in this patient. Data was obtained 
primarily and secondarily. In this case, a 32 years old male was referred to our clinic with chief 
complaints of headache since a week prior and a seizure 5 days ago. A head CT and a CT 
angiography (CTA) of the circulus willisi were done and a bilateral and symmetrical calcification of 
the corona radiata, basal ganglia, thalamus, and nucleus dentatus were found. There is also 
hypocalcemia and low Parathyroid Hormone (PTH). Fahr’s Syndrome may manifest unusually and 
hence clinicians have to be aware of diagnosing this entity. 
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ABSTRAK 
Sindroma Fahr’s merupakan sebuah penyakit yang ditandai dengan kalsifikasi bilateral sietris dari 
basal ganglia dengan gejala psikatri dan parkinsonisme. Namun, akibat jarangnya ditemukan 
penyakit ini, klinisi cenderung tidak memikirkan sindroma Fahr’s sebagai salah satu diagnosis 
banding. Artikel ini bertujuan untuk meningkatkan kewaspadaan terhadap diagnosis Sindroma Fahr’s 
melalui presentasi unik pada pasien ini. Data diambil secara primer dan sekunder. Pada kasus ini, 
seorang laki-laki berusia 32 tahun dirujuk dengan keluhan utama sakit kepala sejak satu minggu dan 
kejang 5 hari sebelum masuk rumah sakit. Computed Tomography (CT) scan kepala dan Computed 
Tomography Angiography (CTA) dari sirkulus willisi dilakukan dan ditemukan adanya kalsifikasi 
bilateral simetris pada korona radiata, basal ganglia, talamus dan nukleus dentatus. Pada 
pemeriksaan laboratorium ditemukan adanya hipokalsemia dan hormon paratiroid (PTH) yang 
rendah. Sindroma Fahr’s dapat datang dengan presentasi yang tidak khas sehingga para klinisi 
harus lebih tajam dalam mendiagnosis kasus ini.  




      Fahr’s syndrome is a syndrome that is 
rarely encountered that is characterized by 
symmetrical bilateral calcification in basal 
ganglia with a prevalence of <1 in 
1,000,000 people.[1] There is a limited 
amount of studies about Fahr’s syndrome 
where epidemiologic studies show a wide 
range of Fahr’s syndrome according to 
computed tomography (CT) findings, 
ranging from 0.49% to 10.02%.[2] 
      Main diagnostic criteria for Fahr’s 
syndrome is symmetricaland bilateral 
calcification in basal ganglia. Fahr’s 
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dysfunction such as involuntary 
movements and or neuropsychiatric 
manifestations with an onset from 4th to 5th 
decade, no biochemical abnormalities or 
somatic features suggestive of metabolic, 
mitochondrial or other systemic diseases, 
no infectious, toxic or traumatic causes 
and no family history that is consistent 
with genetically inherited autosomal 
dominant disease.[2,3] 
      Fahr’s disease must be differentiated 
from Fahr’s sydrome. Patients with Fahr's 
disease usually suffer from the disease at 
the age of 40-60 years while in patients 
with Fahr’s syndrome usually has an onset 
at the age of 30-40 years. Fahr’s disease is 
genetically related while Fahr’s syndrome 
is not genetic. Calcification of Fahr's 
syndrome occurs suddenly but occurs 
slowly in patients with Fahr’s disease. 
Fahr’s syndrome can also be misdiagnosed 
with a stroke due to motor impairment.[2] 
      This evidence-based case report will 
discuss about clinical and radiological 
manifestations of Fahr’s syndrome with 
unique presentation and how to 
differentiate it with other clinical entities. 
. 
 
      Primary data is collected by means of 
direct clinical examination and secondary 
data is coollected by means of medical 
records. 
 
       A 32-year-old male is referred to our 
hospital with subarachnoid bleeding as his 
diagnosis due to aneurysm rupture with 
headache as his primary complaints for 
one week before admission. He also 
complained of seizure 5 days before 
admission. No abnormalities were found in 
physical examination except severe pain 
with a visual analogue scalescore of 8. CT 
angiography (CTA) ofcircle of willis was 
done to exclude subarachnoid bleed and 
the result was normal hence a brain CT 
scan without contrast was done and 
symmetrical and bilateral calcification was 
found in corona radiata, basal ganglia, 
thalamus anddentate nucleus (figure 1). 
Laboratory findings found that there is a 
minimal elevation of SGOT and SGPT, 
low PTH (10.1 pg/mL) and hypocalcemia 
(1.21 mmol/L).Immunologic test was 
positive for anti-histone and EUROline 
scan was strongly positive. Serologic test 
for herpes, toxoplasmosis and HIV were 
negative. The patient was treated with 
calcium carbonate two times daily, 
tizanidine 2 mg three times daily and 
cavit-D3 three times daily. 
      Authors searched Pubmed and Google 
Scholar with keywords such as “fahr [All 
Fields] AND ("syndrome"[MeSH Terms] 
OR "syndrome"[All Fields])”and the 
search is done on 4thAgustus 2019 (figure 
2). 
       
Figure 1. Basal ganglia and dentate nucleus calcification (left), bilateral corona radiata calcification 
(middle) and thalamus (right) 
























Figure 2. Algorithm of literature search and selection 
 
     Fahr's disease was discovered by Karl 
Theodor Fahr in 1930 when he diagnosed 
a 55-year-old male patient with dementia, 
hypothyroidism, immobility without 
paralysis and basal ganglia calcification 
with Fahr's disease.[4,5] The diagnostic 
criteria for Fahr's disease is quite uniform, 
unlike diagnostic criteria for Fahr's 
syndrome which varied in each study 
(table 1). Fahr’s syndrome is defined as 
the presence of striatiopallidal symmetrical 
bilateral calcifications on the base of 
cranium.[11] There are more than 50 
clinical conditions associated with Fahr’s 
syndrome (table 2) and parathyroid disease 
is one of the most common causes. [2,12,13] 
Clinical manifestations of Fahr’s 
syndrome vary from neurological to 
cardiological (table 3). The diagnosis of 
Fahr's syndrome requires a CT scan that 
shows bilateral symmetrical calcifications 
involving the striatum, pallidum with or 
without deposits in the nucleus dentatus, 
thalamus and white matter.[5] Magnetic 
resonance imaging (MRI) cannot be used 
as the main radiological modality in 
diagnosing Fahr's syndrome due to varying 
signal intensities and depending on the 
proton density of calcium, other mineral 
ions, concentrations of binding proteins 
and mucopolysaccharides in various stages 
of the disease or varying metabolic 
stages.[16,17] Management for Fahr's 
syndrome is targeted to the underlying 
conditions of Fahr's syndrome with 
symptomatic treatment as adjuvants.[10] 
Anticonvulsants can be given to overcome 
seizures and movement disorders caused 
by PTH. Calcium supplementation and 
alpha hydroxyl vitamin D3 can correct 
serum calcium and phosphate.[18] Fahr's 
syndrome has infrequent complications 
such as Morbus Fahr and overactive 
bladder.[19,20] In this patient, the diagnosis 
of Fahr's syndrome is delayed due to a 
referral diagnosis in the form of 
subarachnoid hemorrhage. The diagnosis 
of Fahr’s syndrome is made using head CT 
scan with symmetrical bilateral 
calcification findings on the corona 
radiata, basal ganglia, thalamus and 
dentatus nucleus. The discovery of PTH 
and low calcium and 32 years of age 




Total citations identified from Pubmed (n = 92) 
 
Citations excluded after title and/or abstract screening (n= 15) 
 
Selected articles are further evaluated (n= 77) 
 
Exclusions due to: 
- Literature dated 2007 and earlier (n= 35) 
- No manuscript in English or Indonesian 
available (n= 9) 
- Fahr's disease (n=4) 
- Genetically inclined article (n= 4) 












Table 1. Comparison in criteria used to diagnose Fahr’s Syndrome 
 
Author(Year) Diagnostic Criteria Study type 
Lowenthal et al (1986)[6] (1) Calcification with a characteristic distribution or at 
least affects globus pallidus with or without cerebellum 
calcification;  
(2) Obvious calcification seen in CT scan; 
(3) Calcification should be big enough to be detected in 
macroscopic examination  
Literature 
Review 
Saleem et al (2013)[2]; 
Modified from 
Moskowitz et al (1971)[7], 
Ellie et al. (1989)[8], 
Manyam (2005)[9] 
1) Bilateral calcification in basal ganglia or other 
regions  in radiologic examination; 
2) Progressive neurologic dysfunction that involves 
motoric dysfunction and or neuropsychiatric 
manifestations. Onset begins at 40-50 years old even 
though it may manifest during childhood. 
3) No biochemical and somatic etiologies that are 
suggestive for mitochondrial, metabolic or systemic 
dysfunctions.  
4) No infectious, toxic or traumatic causes.  
Literature 
Review 
Malathi et al (2016)[10] Consider Fahr’s syndrome if:  
a) Onset starts from 30–40years 
b) Evidence of bilateral and symmetrical intracranial 
calcification  
AND 
Presence of endocrinopathies such as: 
a) Idiopathic hypoparathyroidism  





Presence of one or more comorbids below: 
a) Intrauterine or perinatal brucellosis  
b) Neuroferritinopathy 
c) Polycystic lipomembranous osteodisplasia with 
sclerosing leukoencephalopathy 
d) Cockayne syndrome 
e) Aicardi-Gouteres syndrome 
f) Tuberous sclerosis 
g) Myopathy mitochondrial  
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Table 2. Classification of diseases associated with Fahr’s syndrome 
 
Author (Year) Clinical Condition Study Type 
Categories Example 




























Down syndrome, lupus, 
tuberous sclerosis 













iron deposits in brain,  
neuroferritinopathy 
Infection Intrauterine and 
perinatal infection 
Cockayne syndrome 
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Baba et al (2005)[15] Sporadic conditions with 
metabolism abnormalities 
from calcium, phosphor 











abnormalities  without 
from calcium, phosphor 










abnormalities  without 
from calcium, phosphor 





difus, Fahr’s disease 
Others Aging process 
Hereditary familial 
condition with metabolism 
abnormalities from 

















type 1 syndrome, Fahr’s 
disease 
 Hereditary familial 
condition with unknown 
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Table 3. Clinical Manifestation in Fahr’s Syndrome 
 
Author(Year) Clinical Presentation Study type 
Organ Specific Presentation 
















Movement disorder Easily fatigued 
Unstable gait 
Involuntary movement 







Inability to make 
decisions 
Marlena et al (2009)[21] Neurologic Recurrent syncope Case Report 
Cardiologic Hypocalcemic 
cardiomyopathy 
      Fahr’s syndrome is a constellation of 
syndrome that is increasingly common to 
be found although the knowledge about 
this disease is still largely unknown. 
Clinicans are encouraged to include this 
syndrome in the differential diagnosis 
when a patient presents with neurologic 
complaints that are suggestive of Fahr’s 
syndrome. Finding out the underlying 
disease(s) or comorbid(s) is also 
imperative as it will affect the treatment 
for the patient. 
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